With $270 million settlement, Purdue Pharma starts paying for the opioid crisis
Post Reports
The Washington Post
4.4 • 5.1K Ratings
🗓️ 26 March 2019
⏱️ 17 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | From the newsroom of the Washington Post. |
| 0:05.0 | It's Robert Samuels from the Washington Post. |
| 0:08.0 | Post is Sarah Kaplan. |
| 0:10.0 | Hi, this is Elaheiz Adi with the Washington Post. |
| 0:13.0 | Hey, I'm Arnie. |
| 0:14.0 | This is Post Reports. |
| 0:15.0 | I'm Martin Powers. |
| 0:18.0 | It's Tuesday, March 26. |
| 0:21.0 | Today, a major settlement and a landmark opioid lawsuit. |
| 0:27.0 | Florida Republicans seek to limit a voting rights amendment, plus butterflies in the border wall. |
| 0:35.0 | On Tuesday, Purdue Pharma, the creator of OxyContin, agreed to settle a lawsuit with the state of Oklahoma. |
| 0:44.0 | That lawsuit centered on Purdue's role in the opioid crisis. |
| 0:49.0 | The addiction crisis facing our state and nation is a clear and present danger. |
| 0:55.0 | But we are doing something about it today. |
| 0:58.0 | This begins a new chapter for those struggling with addiction. |
| 1:02.0 | Purdue Pharma has been accused of deceptively marketing the medication of pushing it to doctors, |
| 1:08.0 | of trying to get doctors to prescribe huge doses of it so they can make more money. |
| 1:13.0 | And they've been accused of this for years. |
| 1:16.0 | Katie Zezma is a national reporter for the Post. |
| 1:19.0 | She's been following this Purdue Pharma lawsuit for a while. |
| 1:24.0 | The company vigorously denies all of the allegations made against it. |
| 1:28.0 | But Katie says that the $270 million settlement is still a huge step. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Washington Post, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Washington Post and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.